DCGI issues guidelines for pharma giants
23 Sept, 2020

New Delhi: The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunoge.....

Read More
Dr Reddy's seeks DCGI nod to conduct pha
03 Oct, 2020

NEW DELHI : The Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for per.....

Read More
Zydus Cadilla completes Phase II trials
13 Nov, 2020

Company’s biological drug, Pegylated Interferon alpha – 2b significantly reduced the viral load in moderatel.....

Read More
Serum Institute denies side effects clai
01 Dec, 2020

After a Chennai-based man claimed that he suffered neurological and psychological side effects taking a shot of Covid-19.....

Read More
Zydus Cadila gets DGCI nod for phase 3 c
05 Dec 2020

In a regulatory filing, Zydus Cadila said it has received approval from the DCGI to start the phase 3 clinical trials in.....

Read More
AEFI reporting to be done through Co-WIN
17 Dec, 2020

Need to build on the standard principles of AEFI, make it specific to COVID-19 vaccines: Dr V K Paul In the course of.....

Read More
A great milestone in India scientific ca
04 Jan, 2021

Expressing delight over the approval on restricted emergency use of its COVID-19 vaccine Covaxin, Bharat Biotech on Sund.....

Read More
Vaccine restricted use considered based
06 Jan, 2021

In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data whil.....

Read More
Serum Institute and Bharat Biotech call
06 Jan, 2021

After publicly trading barbs over the efficacy of their respective vaccines, Serum Institute of India chief executive of.....

Read More
Bharat Biotech, SII approach DCGI for us
29 Jan, 2021

ICMR chief Balram Bhargava on Thursday said COVID-19 vaccine manufacturers–Bharat Biotech and Serum Institute&ndas.....

Read More
Dr Reddys eyes to launch Sputnik V vacci
30 Jan, 2021

Dr Reddys Laboratories, which is conducting Phase 3 trials of Russia’s COVID-19 vaccine Sputnik V, believes the ja.....

Read More
Kochi firm PNB Vesper Life completes pha
23 Feb, 2021

The city-based PNB Vesper Life Sciences has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its.....

Read More
Zydus Cadila seeks DCGI nod for use of h
06 April 2021

Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General o.....

Read More
Expert panel to review Meril price exemp
22 April 2021

NEW DELHI : Meril Life Sciences Pvt. Ltd’s request for exemption from price caps for its first locally-made biodeg.....

Read More
Zydus Cadila - Virafin gets emergency us
24 April 2021

Amid a continuous spike in the number of coronavirus cases in India, Zydus Cadila’s Virafin has been granted emerg.....

Read More
Bharat Biotech seeks DCGI nod to extend
26 April 2021

Bharat Biotech has written to the India’s drug regulator seeking extension of the shelf-life of its indigenously d.....

Read More
Molnupiravir approval sought to target e
27 April 2021

After an outcry for remdesivir, there is now yet another experimental anti-viral drug – Molnupiravir to deal with .....

Read More
AIIMS Delhi to start screening children
07 June, 2021

The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigen.....

Read More
US denying emergency approval to Covaxin
12 June, 2021

In the view of the US FDA rejecting emergency use authorisation to Bharat Biotech’s Covaxin, the government Friday.....

Read More
India likely to have Covid vaccine for c
24 June, 2021

Noting that children usually have a mild disease but there is a need to develop Covid-19 vaccines for them, AIIMS Delhi .....

Read More
Pfizer in final stages of getting approv
24 June, 2021

New Delhi: US pharmaceutical giant Pfizer on Tuesday said it is in the "final stages" of getting approval for .....

Read More
Drug regulator DCGI refuses to grant eme
02 July 2021

India’s drug regulator has refused to grant emergency-use authorisation to single-dose COVID-19 vaccine Sputnik-Li.....

Read More
Zydus seeks nod for world-first plasmid
02 July 2021

Ahmedabad: Homegrown healthcare and pharmaceutical major Zydus Cadila has applied for emergency use authorisation (EUA) .....

Read More
Working actively with Moderna to see how
10 July, 2021

The government said on Friday that it is working actively with COVID-19 vaccine manufacturer Moderna to see how its vacc.....

Read More
DRDO COVID-19 drug: BDR Pharma inks lice
27 July, 2021

BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to.....

Read More
Hopeful of launching Covovax for adults
06 Aug, 2021

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being m.....

Read More
Zydus Cadila likely to get emergency use
10 Aug, 2021

Ahmedabad-based Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D is expected to get an emergency-use nod from the .....

Read More
DCGI nod to phase-I clinical trial of CO

The firm is required to submit the revised clinical trial protocol for immunogenicity to be assessed on Day 42, instead .....

Read More
Hetero’s Tocilizumab biosimilar ge

This authorisation will enable medical practitioners to use the drug for the treatment of COVID-19 in hospitalised adult.....

Read More
Molbio Diagnostics gets DCGI nod for Nip

Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from as.....

Read More
No Delta plus variant of COVID-19 found

Additional municipal commissioner (western suburbs) Suresh Kakani said the samples were examined at a genome sequencing .....

Read More
AstraZeneca Pharma India gets DCGI nod t

The company has received the import and market permission in Form CT-20 from the Drugs Controller General of India for S.....

Read More